Page 34 - Cara News Today

Limoneira (NASDAQ:LMNR – Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $15.22 and traded as high as $15.54. Limoneira shares last traded at $15.30, with a volume of 105,394 shares trading hands. Wall Street Analysts Forecast Growth A number of research analysts […]

Limoneira (NASDAQ:LMNR – Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $15.22 and traded as high as $15.54. Limoneira shares last traded at $15.30, with a volume of 105,394 shares. Analysts Set New Price Targets Several research analysts recently issued […]

Limoneira (NASDAQ:LMNR – Free Report) announced a quarterly dividend on Wednesday, June 28th, Zacks reports. Investors of record on Tuesday, July 11th will be given a dividend of 0.075 per share on Friday, July 14th. This represents a $0.30 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Monday, […]

The state of Chilean imports following rains and flooding

Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) SVP Frederique Ph.D. Menzaghi sold 2,993 shares of the business’s stock in a transaction dated Friday, June 23rd. The shares were sold at an average price of $3.51, for a total value of $10,505.43. Following the completion of the transaction, the senior vice president now directly owns 153,747 […]

Kelly Wearstler designed Dahlia, her latest in a string of projects for the Proper Hospitality brand.

The Westport woman who owns Chou Chou, a womens clothing boutique, has opened a second location in Ridgefield to go with her outlet in Norwalk.

Flu season turns our focus to citrus fruit. Its availability on our grocery shelves is timed just right to build our immune resources with the Vitamin C it contains. Or why not adopt a long-term plan. Plant a citrus tree to enjoy its fruit before it undergoes all the stages to preserve it and keep it disease free.

Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) has received a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average twelve-month price objective among brokers that have […]

Summer is Hollywood Bowl season. Whether you’re in a box or more affordable seat, there’s an overflow of good food to bring for dinner before the show.